Home/Investors/SV Health Investors

SV Health Investors

Biotech Investor · 10 portfolio companies

Portfolio

10

Focus Areas

17

Top Stage

Pre-clinical

Investment Focus

Immunology Oncology Metabolic Ophthalmology Cardiovascular Coronary Artery Disease Urology Pelvic Health Metabolic Disorders Endocrine Disorders Neuropsychiatry Major Depressive Disorder Dermatology Gastroenterology Parkinson's Disease

Portfolio Companies

Company	Stage	Valuation	Focus
Sitryx Therapeutics	preclinical	—	Immunology, Oncology
EyeBio	phase-2	—	Ophthalmology
SpectraWAVE	Commercial	—	Cardiovascular, Coronary Artery Disease
EBT Medical	Pre-clinical	—	Urology, Pelvic Health
Extend Biosciences	Phase 2	—	Metabolic Disorders, Endocrine Disorders
Draig Therapeutics	Phase 2	—	Neuropsychiatry, Major Depressive Disorder
Enara Bio	Pre-clinical	—	Oncology
TRexBio	Phase 1	—	Immunology, Oncology
EndLyz Therapeutics	Pre-clinical	—	Parkinson's Disease, Neurodegenerative Diseases
The Bland Company	platform	—	Immunology, Oncology

Frequent Co-Investors

Samsara BioCapital2 shared Atlas Venture1 shared Deerfield Management1 shared Sofinnova Partners1 shared Gurnet Point Capital1 shared Access Biotechnology1 shared Pfizer Ventures1 shared Sanofi Ventures1 shared